Background The effect of different anticoagulants on recanalization after cerebral venous
thrombosis has not been studied in a randomized controlled trial. Methods RE-SPECT CVT …

Background and Purpose—The role of recanalization of the occluded dural sinus or vein in
the outcome of patients with cerebral venous thrombosis (CVT) is not established. We aimed …

Background and Purpose—Thrombosis of cerebral veins and sinus (cerebral venous
thrombosis) is a rare stroke pathogenesis. Pharmaceutical treatment is restricted to heparin …

Background: A small randomized controlled trial suggested that dabigatran may be as
effective as warfarin in the treatment of cerebral venous thrombosis (CVT). We aimed to …

Rationale To prevent recurrent venous thrombotic events after acute cerebral venous or
dural sinus thrombosis, guidelines recommend long-term oral anticoagulation with vitamin K …

Background and Purpose: This analysis examined the frequency of dural arteriovenous
fistulae (dAVF) after cerebral venous thrombosis (CVT) in patients included in a randomized …

Background Recanalization in cerebral venous thrombosis (CVT) can begin as early as one
week after initiating therapeutic anticoagulation. The clinical significance of recanalization …

Background and Purpose—The hypothesis that venous recanalization prevents progression
of venous infarction is not established in patients with cerebral venous thrombosis (CVT) …

Background Cerebral vein thrombosis is a rare cause of stroke with significant risk of death
and long-term dependency. Anticoagulation has been associated with better long-term …

Rationale Endovascular thrombolysis, with or without mechanical clot removal, may be
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT) who have …